Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J A Spinolo

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
The American Journal of Medicine|December 1, 1992
Acute myelogenous leukemiaJ A Spinolo
Leukemia|January 1, 1992
Autologous bone marrow transplantation in acute lymphocytic leukemia (ALL)K A Dicke, J A Spinolo
Bone Marrow Transplantation|January 1, 1989
High dose therapy and autologous bone marrow transplant (ABMT) in acute leukemia: is purging necessary?K A Dicke, J A Spinolo
Haematology and Blood Transfusion|January 1, 1990
Role of autologous bone marrow transplantation in acute leukemiaK A Dicke, M J Evinger-Hodges, J A Spinolo, et al.
Bone Marrow Transplantation|January 1, 1989
Detection of minimal residual disease in acute myelogenous leukemia by RNA-in situ hybridizationM J Evinger-Hodges, J A Spinolo, V Spencer, et al.
Bone Marrow Transplantation|July 1, 1990
Double intensification including autologous bone marrow transplantation (ABMT) in AML: long term follow-up and detection of residual diseaseK A Dicke, M J Dicke-Evinger, J A Spinolo, et al.
Leukemia & Lymphoma|January 1, 1993
Cisplatin-CBV with autologous bone marrow transplantation for relapsed Hodgkin's diseaseJ A Spinolo, S Jagannath, W Velásquez, et al.
Bone Marrow Transplantation|February 1, 1990
Double intensification with amsacrine/high dose ara-C and high dose chemotherapy with autologous bone marrow transplantation produces durable remissions in acute myelogenous leukemiaJ A Spinolo, K A Dicke, L J Horwitz, et al.
Cancer|January 15, 1992
Second bone marrow transplants for relapsed leukemiaJ A Spinolo, J C Yau, K A Dicke, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 11, 1992
Therapy of relapsed or refractory low-grade follicular lymphomas: factors associated with complete remission, survival and time to treatment failureJ A Spinolo, F Cabanillas, D O Dixon, et al.
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
The American Journal of Medicine|December 1, 1992
Acute myelogenous leukemiaJ A Spinolo
Leukemia|January 1, 1992
Autologous bone marrow transplantation in acute lymphocytic leukemia (ALL)K A Dicke, J A Spinolo
Bone Marrow Transplantation|January 1, 1989
High dose therapy and autologous bone marrow transplant (ABMT) in acute leukemia: is purging necessary?K A Dicke, J A Spinolo
Haematology and Blood Transfusion|January 1, 1990
Role of autologous bone marrow transplantation in acute leukemiaK A Dicke, M J Evinger-Hodges, J A Spinolo, et al.
Bone Marrow Transplantation|January 1, 1989
Detection of minimal residual disease in acute myelogenous leukemia by RNA-in situ hybridizationM J Evinger-Hodges, J A Spinolo, V Spencer, et al.
Bone Marrow Transplantation|July 1, 1990
Double intensification including autologous bone marrow transplantation (ABMT) in AML: long term follow-up and detection of residual diseaseK A Dicke, M J Dicke-Evinger, J A Spinolo, et al.
Leukemia & Lymphoma|January 1, 1993
Cisplatin-CBV with autologous bone marrow transplantation for relapsed Hodgkin's diseaseJ A Spinolo, S Jagannath, W Velásquez, et al.
Bone Marrow Transplantation|February 1, 1990
Double intensification with amsacrine/high dose ara-C and high dose chemotherapy with autologous bone marrow transplantation produces durable remissions in acute myelogenous leukemiaJ A Spinolo, K A Dicke, L J Horwitz, et al.
Cancer|January 15, 1992
Second bone marrow transplants for relapsed leukemiaJ A Spinolo, J C Yau, K A Dicke, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 11, 1992
Therapy of relapsed or refractory low-grade follicular lymphomas: factors associated with complete remission, survival and time to treatment failureJ A Spinolo, F Cabanillas, D O Dixon, et al.
Pageof 2